Pinnacle Bancorp’s Immunocore IMCR Stock Holding History

Pinnacle Bancorp’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-190	Closed	-$9.39K	–	784
2023 Q1	$9.39K	Buy	+190	New	+$10.7K	﹤0.01%	629

Other funds holding IMCR

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pinnacle Bancorp's IMCR Position: Q2 2023 in Review

Pinnacle Bancorp sold out of Immunocore (IMCR) in Q2 2023, closing a stake of 190 shares — an estimated $9.39K sold.

Pinnacle Bancorp first reported a position in IMCR in Q1 2023 and held it in 1 quarter. The position peaked at $9.39K in Q1 2023. 120 funds tracked by Wall St. Rank hold IMCR as of Q2 2023.

Pinnacle Bancorp reported no remaining Immunocore position as of Q2 2023 after selling out during the quarter.
Pinnacle Bancorp sold 190 Immunocore shares in Q2 2023, an estimated $9.39K.
Pinnacle Bancorp first reported a position in Immunocore in Q1 2023 and held it in 1 quarter.
Pinnacle Bancorp's Immunocore position peaked at $9.39K in Q1 2023.
120 funds tracked by Wall St. Rank held Immunocore as of Q2 2023.

Based on Pinnacle Bancorp's 13F filing for Q2 2023, filed 14 Jul 2023.